Nucleic acid constructs and cells, and methods utilizing...

Details Nucleic acid constructs and cells, and methods utilizing... Nucleic acid constructs and cells, and methods utilizing...

2011-08-30

2011-08-30

Li, Q. Janice (Department: 1633)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Reexamination Certificate

active

08007779

ABSTRACT:
Polynucleotide expression constructs, populations of cells and methods of treating diseases caused by dysfunction in, or damage to, excitable tissues are provided.

REFERENCES:
patent: 5602301 (1997-02-01), Field
patent: 5837220 (1998-11-01), Blake et al.
patent: 5955259 (1999-09-01), Holmes et al.
patent: 6013766 (2000-01-01), Elgoyhen et al.
patent: 6087488 (2000-07-01), Ganetzky et al.
patent: 6099832 (2000-08-01), Mickle et al.
patent: 6100046 (2000-08-01), Elgoyhen et al.
patent: 6110459 (2000-08-01), Mickle et al.
patent: 6864364 (2005-03-01), Splawski et al.
patent: 7294333 (2007-11-01), Feld et al.
patent: 7491385 (2009-02-01), Feld et al.
patent: 2004/0029148 (2004-02-01), Feld et al.
patent: 2005/0008628 (2005-01-01), Feld et al.
patent: 2008/0112927 (2008-05-01), Feld et al.
patent: 2369812 (2000-10-01), None
patent: 1326879 (2003-07-01), None
patent: WO 00/10604 (2000-03-01), None
patent: WO 00/18903 (2000-04-01), None
patent: WO 00/63434 (2000-10-01), None
patent: WO 02/33111 (2002-04-01), None
patent: WO 02/087419 (2002-11-01), None
patent: WO 2006/018836 (2006-02-01), None
Loscher et al. Neurosci Res 1998;51:196-209.
Folkerth et al. Neurol 1996;46:1219-25.
Lindvall et al. Sci 1990;247:574-7.
Dinsmore, Exp Opin Invest Drugs 1998;7:527-34.
Grisolia, Epilepsy Behavior 2001;2:318-23.
Gaudesius et al. Circ Res 2003;93:421.
Communication Pursuant to Article 96(2) EPC Dated Nov. 2, 2004 From the European Patetn Office Re.: Application No. 01967651.9.
International Preliminary Report on Patentability Dated Apr. 26, 2007 From the International Bureau of WIPO Re.: Application No. PCT/IL2005/000881.
International Search Report and the Written Opinion Dated Feb. 8, 2007 From the International Searching Authority Re.: Application No. PCT/IL05/00881.
Notice of Allowance Dated Oct. 1, 2008 From the US Patent Office Re.: U.S. Appl. No. 10/919,343.
Official Action Dated May 2, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/919,343.
Official Action Dated Apr. 3, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/976,166.
Official Action Dated Feb. 3, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/399,715.
Official Action Dated Oct. 4, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/919,343.
Official Action Dated Feb. 6, 2006 From the US Patent and Trademark Office Re. U.S. Appl. No. 09/691,889.
Official Action Dated Jun. 6, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/919,343.
Official Action Dated Nov. 13, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/919,343.
Official Action Dated Apr. 21, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/399,715.
Official Action Dated Jul. 25, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/919,343.
Official Action Dated Aug. 29, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/919,343.
Official Action Dated Jul. 29, 2005 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/691,889.
Official Action Dated Jan. 30, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/691,889.
Requisition by the Examiner Dated Apr. 20, 2007 From the Canadian Intellectual Property Office Re.: Application No. 2,426,460.
Requisiton by the Examiner Dated Dec. 6, 2007 From the Canadian Intellectual Property Office Re.: Application No. 2,426,460.
Response Dated Feb. 21, 2005 to Communication Pursuant to Article 96(2) EPC of Nov. 2, 2004 From the European Patent Office Re.: Application No. 01967651.9.
Bader et al. “Repair and Reorganization of Minced Cardiac Muscle in the Adult Newt (Notophthalmus viridescens)”, Journal of Morphology, 155(3): 349-357, 1978.
Banerjee “Genasense (Genta Inc.)”, Current Opinion on Investigative Drugs, 2(4):574-580, 2001. Abstract.
Belluardo et al, “Expression of Connexin36 in the Adult and Developing Rat Brain”, Brain Research, 865: 121-138, 2000.
Brukner “INGN-201. Introgen Therapeutics”, Current Opinion on Investigative Drugs, 2(12): 1776-1785, 2001. Abstract.
Chiu et al. “Cellular Cardiomyoplasty: Myocardial Regeneration With Satellite Cell Implantation”, Annual Meeting of the Thoraxic Surgeons, 60:12-18, 1995.
Christ “Gap Junctions and Ion Channels: Relevance to Erectile Dysfunction”, International Journal of Impotence Research, 12(Suppl.4): S15-S25, 2000.
Cohen et al. “ONYX-015-Onyx Pharmaceuticals”, Current Opinion on Investigative Drugs, 2(12): 1770-1775, 2001. Abstract.
Crystal “Transfer of Genese to Humans: Early Lessons and Obstacles to Success”, Science, 270: 404-410, 1995.
DeGroot et al. “Clinical Review 131: Gene Therapy for Thyroid Cancer: Where Do We Stand?”, The Journal of Clinical Endocrinology & Metabolism, 86(7): 2923-2928, 2001.
Deonarain “Ligand-Targeted Receptor-Mediated Vectors for Gene Delivery”, Expert Opinion on Therapeutic Patents, 8(1): 53-69, 1988.
Di Lazzaro et al. “Motor Cortex Hyperexcitability to Transcranial Magnetic Stimulation in Alzheimer's Disease”, Journal of Neurology, Neurosurgery, and Psychiatry, 75: 555-559, 2004.
Donahue et al. “Focal Modification of Electrical Conduction in the Heart by Viral Gene Transfer”, Nature Medicine, 6(12): 1395-1398, 2000.
Donahue et al. “Gene Therapy for Cardiac Arrhythmias”, Trends in Cardiovascular Medicine, TCM, 15(6): 219-224, 2005.
Donahue et al. “Modification of Cellular Communication by Gene Transfer”, Annals New York Academ of Sciences, 1047: 157-165, 2005.
Ebihara et al, “Co-Expression of Lens Fiber Connexins Modifies Hemi-Gap-Junctional Channel Behavior”, Biophysical Journal, 76: 198-206, 1999.
Fast et al. “Anisotropic Conduction in Monolayers of Neonatal Rat Heart Cells Cultured on Collagen Substrate”, Circulation Research, 75(3): 591-595, 1994.
Feld et al. “Electrophysiological Modulation of Cardiomyocytic Tissue by Transfected Fibroblasts Expressing Potassium Channels: A Novel Strategy to Manipulate Excitability”, Circulation, 105(4): 522-529, 2002.
Freed et al. “Survival of Implanted Fetal Dopamine Cells and Neurologic Improvement 12 to 46 Months After Transplantation for Parkinson's Disease”, New England Journal of Medicine, 327(22): 1549-1555, 1992.
Friedmann “Overcoming the Obstacles to Gene Therapy”, Scientific American, 276(6): 96-101, 1997.
Gage “Cell Therapy”, Nature, 392(Suppl.): 18-24, 1998.
Gardlik et al. “Vectors and Delivery Systems in Gene Therapy”, Medical Science Monitor, 11(4): RA110-RA121, 2005.
Gepstein et al. “Somatic Gene and Cell Therapy Strategies for the Treatment of Cardiac Arrhytmias”, American Journal of Physiology—Heart and Circulatory Physiology, 286: H815-H822, 2004.
Grosshans “Gene Therapy—When a Simple Concept Meets a Complex Reality. Review on Gene Therapy”, Functional and Integrative Genomics, 1: 142-145, 2000.
Gussoni et al. “Normal Dystrophin Transcripts Detected in Duchenne Muscular Dystrophy Patients After Myoblast Transplantation”, Nature, 356(6368): 435-438, 1992.
Hammond et al. “Angiogenic Gene Therapy for Heart Disease: A Review of Animal Studies and Clinical Trials”, Cardiovascular Research, 49(3): 561-567, 2001.
Hoppe et al. “Manipulation of Cellular Excitability by Cell Fusion: Effects of Rapid Introducition of Transient Outward K+ Current on the Guinea Pig Action Potential”, Circulation Research, 84: 964-972, 1999.
Jackowski “Neural Injury Repair: Hope for the Future as Barriers to Effective CNS Regeneration Become Clearer”, British Journal of Neurosurgery, 9(3): 303-317, 1995.
Jockusch et al. “Long-Term Expression of Isomyosins and Myoendocrine Functions in Ectopic Grafts of Atrial Tissue”, Proc. Natl. Acad. Sci. USA, 83(19): 7325-7329, 1986.
Johns et al. “Adenovirus-Mediated Expression of a Voltage

Affiliated with

Also associated with

Rating

Nucleic acid constructs and cells, and methods utilizing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid constructs and cells, and methods utilizing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid constructs and cells, and methods utilizing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2632864